AZN vs PLAB · P/E 28, $288.38B cap vs P/E 11, rev $435.0M
AstraZeneca PLC (AZN) versus Photronics Inc (PLAB) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Photronics Inc (PLAB) is a semiconductor equipment & materials company listed on NASDAQ.
AZN does not have a complete income-statement cache yet.
Latest reported PLAB revenue for 2026-05-03 was $435.0M. Net income was $74.4M. Revenue was up 93.3% from 2026-02-01 to 2026-05-03. PLAB currently screens at market cap $1.83B and trailing P/E 11.4.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. PLAB currently screens at market cap $1.83B and trailing P/E 11.4.
Not investment advice. Open the AZN and PLAB stock pages for the full models.
Not investment advice.